Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
about
Diverse virulent pneumophages infect Streptococcus mitisCD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitisCholine Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsBacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infectionRole of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage LysinsBacteriophages and phage-derived proteins--application approachesCharacterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4Cpl-7, a lysozyme encoded by a pneumococcal bacteriophage with a novel cell wall-binding motifSynergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullinBacteriophage endolysins: a novel anti-infective to control Gram-positive pathogensDepolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectivesRecombinant bacteriophage lysins as antibacterialsEvolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.A genomic approach to understand interactions between Streptococcus pneumoniae and its bacteriophagesLysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammationWall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile.Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions.Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.The post-antibiotic era: promising developments in the therapy of infectious diseases.In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.Exploiting what phage have evolved to control gram-positive pathogensMiniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?1st German Phage Symposium-Conference Report.Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
P2860
Q21090561-6299BDF4-8636-49FB-8B2B-D219668BDBDDQ24631662-BB398595-5CED-4887-B77B-F0EF4924B4B0Q26744448-9CF47B5C-DBB2-4810-A565-CD4BB7740452Q26781115-ABD28D6B-F85D-4286-BCC1-4FC39D3BF7E3Q26998053-A07EC436-E8D7-4315-891C-99D58650BC85Q27671535-0375CD38-BB82-4288-8533-70E92BC2962CQ28082731-CA2C3A66-5A4B-499A-A14B-6FA539520682Q30010156-11DFA0C6-91C0-4433-AC21-39C228940A06Q30392766-E3ABA86E-D26E-47CE-AD50-6E7CBC5AF4B2Q33525230-43909D9F-2870-4EFC-BD26-AAF946463FE6Q33749965-70ABAE4B-6F4D-48FB-A2ED-C8AB25979E80Q34114172-1FC75D0B-3BAA-4EE1-B6BE-85B2137B9FDBQ34116324-A8ED2F32-6236-46F0-96A4-BB6A2F5EDE37Q34303439-C2976288-4222-4197-AF04-0B9DDF8806EFQ34349552-78F59F8E-57F2-42BC-BE9F-E63C6E987F2EQ34558237-094B79E8-DA96-43EE-B220-66D800E8E9A0Q35432724-FE8E413E-B8F9-4AB9-BBEA-96ADDFA2DB7BQ35845888-95D7CA02-399B-4D0F-BC19-AB9E7AC2EE4DQ37072798-895AD0D7-0D5C-4DCA-AAE3-6F1E9A301B1CQ37348810-B052BAFC-FC00-40A1-80EC-22FEE5D286CCQ37428714-1FC815E8-752F-45E6-88D3-8819E568F801Q37696606-A42BAEC5-24A2-456D-9770-139B0BC25AC3Q38106970-60605DA1-3D60-408A-964B-934B9AF2C063Q38282910-6CFAABBD-ABF1-459F-BF39-716BC2D8EC18Q38325227-1421F113-DACB-4DEF-989E-A317CBD7913BQ39029801-81DA117C-8FD2-4718-A931-B7BC280726BEQ40071759-BA89747C-3B57-4528-ACA6-B9AF0EC4264CQ40075857-723AB09E-40D8-4DCB-8DD7-965DC8AAC278Q41657153-22ACE2C1-AE29-4972-BEF3-619E228FC828Q41878765-52939BD0-0B1A-431A-9050-BCBB7B4EDA1EQ42072037-A916E6EE-5A2F-49D7-84F1-8A4653964AD1Q42210341-56654DE2-97A3-454C-83AC-E12BC35262B2Q42264677-F26719A8-049D-4367-8078-D9DD112BDA09Q46251747-4C6F85F9-E7E1-45F9-A5CB-9EEBC4A2E3DBQ47588177-F4190C2A-C34B-4D6F-95B5-807787B09156Q50016951-100D6F4F-26F3-4D3C-8A79-59B29DE885DCQ52622270-38B73E60-0EED-4A90-8840-0D6DDC1F560EQ52679093-5B1EFB30-F98E-46A2-B9AD-12F175B91682Q54247935-80C8601B-8A84-44D8-86C8-469CE97C9A02Q59128002-0122C822-72A4-43FC-8523-9EF98E7C2374
P2860
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@en
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@nl
type
label
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@en
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@nl
prefLabel
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@en
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
@nl
P2093
P1476
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia
@en
P2093
Birgitt Gutbier
Hartwig Schütte
Holger Müller
Jan M Doehn
Janine Zahlten
Jutta M Loeffler
Maren Zemlin
Martin Witzenrath
Norbert Suttorp
Simone Rosseau
P304
P356
10.1097/CCM.0B013E31819586A6
P407
P577
2009-02-01T00:00:00Z